[1] BASSOTTI G, USAI SATTA P, BELLINI M. Chronic idiopathic constipation in adults: a review on current guidelines and emerging treatment options[J]. Clin Exp Gastroenterol, 2021, 14:413-428.
[2] SCHMIER J K, MILLER P E, LEVINE J A, et al. Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model[J]. BMC Public Health, 2014, 14:374.
[3] PAPI S, BARMALA A, AMIRI Z, et al. Mediating roles of stress, anxiety, and depression in the relationship between constipation and sleep quality among the elderly: structural equation modeling (SEM)[J]. Sleep Sci, 2023, 16(1):1-6.
[4] OTANI K, WATANABE T, TAKAHASHI K,et al. Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check-up in Japan[J]. J Gastroenterol Hepatol, 2021, 36(8):2157-2164.
[5] MIKKELSEN K, STOJANOVSKA L, POLENAKOVIC M, et al. Exercise and mental health[J]. Maturitas, 2017, 106:48-56.
[6] FIRTH J, GANGWISCH J E, BORISINI A, et al. Food and mood: how do diet and nutrition affect mental wellbeing?[J]. BMJ, 2020, 369:m2382.
[7] DETER H C, ALBERT W, WEBER C, et al. Does anxiety affect survival in patients with coronary heart disease?[J]. J Clin Med, 2023, 12(6):2098.
[8] BLACK C J, DROSSMAN D A, TALLEY N J, et al. Functional gastrointestinal disorders: advances in understanding and management[J]. Lancet, 2020, 396(10263):1664-1674.
[9] O’MALLEY D. Immunomodulation of enteric neural function in irritable bowel syndrome[J]. World J Gastroenterol, 2015, 21(24):7362-7366.
[10] FIKSDAL A, HANLIN L, KURAS Y, et al. Associations between symptoms of depression and anxiety and cortisol responses to and recovery from acute stress[J]. Psychoneuroendocrinology, 2019, 102:44-52.
[11] FRIEDMAN E M, IRWIN M R. A role for CRH and the sympathetic nervous system in stress-induced immunosuppression[J]. Ann N Y Acad Sci, 1995, 771:396-418.
[12] MARTIN C R, OSADCHIY V, KALANI A, et al. The brain-gut-microbiome axis[J]. Cell Mol Gastroenterol Hepatol, 2018, 6(2):133-148.
[13] FOSTER J A, MCVEY NEUFELD K A. Gut-brain axis: how the microbiome influences anxiety and depression[J]. Trends Neurosci, 2013, 36(5):305-312.
[14] TOUBIA T, KHALIFE T. The endogenous opioid system: role and dysfunction caused by opioid therapy[J]. Clin Obstet Gynecol, 2019, 62(1):3-10.
[15] DRAGOŞ D, TÄNÄSESCU M D. The effect of stress on the defense systems[J]. J Med Life, 2010, 3(1):10-18.
[16] MEDIAVILLA C. Bidirectional gut-brain communication: a role for orexin-A[J]. Neurochem Int, 2020, 141:104882.
[17] GREENWOOD-VAN MEERVELD B, JOHNSON A C, GRUNDY D. Gastrointestinal physiology and function[J]. Handb Exp Pharmacol, 2017, 239:1-16.
[18] SUDA K, MATSUDA K. How microbes affect depression: underlying mechanisms via the gut-brain axis and the modulating role of probiotics[J]. Int J Mol Sci, 2022, 23(3):1172.
[19] FOND G, LOUNDOU A, HAMDANI N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis[J]. Eur Arch Psychiatry Clin Neurosci, 2014, 264(8):651-660.
[20] TACHÉ Y, BONAZ B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function[J]. J Clin Invest, 2007, 117(1):33-40.
[21] SHARMA A, RAO S. Constipation: pathophysiology and current therapeutic approaches[J]. Handb Exp Pharmacol, 2017, 239:59-74.
[22] GOSMANN N P, COSTA M A, JAEGER M B, et al. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis[J]. Psychol Med, 2023, 53(9):3783-3792.
[23] CARDINALI D P, SRINIVASAN V, BRZEZINSKI A, et al. Melatonin and its analogs in insomnia and depression[J]. J Pineal Res, 2012, 52(4):365-375.
[24] NARAYANAN S P, BHARUCHA A E. A practical guide to biofeedback therapy for pelvic floor disorders[J]. Curr Gastroenterol Rep, 2019, 21(5):21.
[25] PARKER C H, HENRY S, LIU L W C. Efficacy of biofeedback therapy in clinical practice for the management of chronic constipation and fecal incontinence[J]. J Can Assoc Gastroenterol, 2019, 2(3):126-131.
[26] BA-BAI-KE-RE M M, WEN N R, HU Y L, et al. Biofeedback-guided pelvic floor exercise therapy for obstructive defecation: an effective alternative[J]. World J Gastroenterol, 2014, 20(27):9162-9169.
[27] BATTAGLIA E, SERRA A M, BUONAFEDE G, et al. Long-term study on the effects of visual biofeedback and muscle training as a therapeutic modality in pelvic floor dyssynergia and slow-transit constipation[J]. Dis Colon Rectum, 2004, 47(1):90-95.
[28] HJELLAND I E, SVEBAK S, BERSTAD A, et al. Breathing exercises with vagal biofeedback may benefit patients with functional dyspepsia[J]. Scand J Gastroenterol, 2007, 42(9):1054-1062.
[29] BLACK C J, THAKUR E R, HOUGHTON L A, et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis[J]. Gut, 2020, 69(8):1441-1451.
[30] NIKJOOY A, KHOSHLAHJEH SEDGH A, MAHJOUBI B, et al. The effects of cognitive behavioral therapy with biofeedback therapy on the quality of life, anxiety, depression and somatic symptoms in patients with dyssynergic defecation: a randomized controlled trial[J]. Med J Islam Repub Iran, 2022, 36:74.
[31] HOUSEHAM A M, PETERSON C T, MILLS P J, et al. The effects of stress and meditation on the immune system, human microbiota, and epigenetics[J]. Adv Mind Body Med, 2017, 31(4):10-25.
[32] MATZEl K E. The role of sacral nerve stimulation in treating faecal incontinence and refractory constipation. Editorial[J]. Colorectal Dis, 2011, 13(Suppl 2):Ⅲ-Ⅳ. |
